Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.2891
H.R.2891: Preserve Access to Affordable Generics and Biosimilars Act
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced April 28, 2021
- Latest Major Action Sept. 29, 2021
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
7 (4 Democrats, 3 Republicans)
Bill Version
- Introduced in House - April 28, 2021
Bill Summary
Preserve Access to Affordable Generics and Biosimilars Act This bill authorizes the Federal Trade Commission (FTC) to initiate proceedings against parties to any agreement resolving or settling a patent infringement claim in connection with the sale of a drug or biological product. Such an agreement is presumed to have anticompetitive effects and is a violation of this bill if the filer of the generic drug or biosimilar application receives...
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| Sept. 29, 2021 |
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 13.
|
| Sept. 29, 2021 |
Committee Consideration and Mark-up Session Held.
|
| April 29, 2021 |
Referred to the Subcommittee on Health.
|
| April 28, 2021 |
Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
| April 28, 2021 |
Introduced in the House by Jerrold Nadler (D-N.Y.) |